Overview
- 185 inspections across 143 sites are on record.
- 600 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-03.
At a glance
Inspections
185
Sites
143
Observations
600
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Immunex Rhode Island Corporation | 3 Jun 2026 | Human Drugs | |
| Perrigo New York, Inc. | 8 May 2026 | Human Drugs | View 483 → |
| Tender Corporation D/B/A Adventure Ready Brands | 10 Apr 2026 | Human Drugs | View 483 → |
| Vertex Pharmaceuticals Incorporated | 3 Mar 2026 | Human Drugs | |
| N-Molecular, Inc. | 5 Feb 2026 | Human Drugs |
Sites inspected
Immunex Rhode Island CorporationWest Greenwich, United States1 insp.
Perrigo New York, Inc.Bronx, United States1 insp.
Tender Corporation D/B/A Adventure Ready BrandsLittleton, United States1 insp.
Vertex Pharmaceuticals IncorporatedBoston, United States1 insp.
N-Molecular, Inc.Colonie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Armen H Youssoufian6 shared
Jonathan G Matrisciano5 shared
Lori M Newman5 shared
Joseph T Frost5 shared
Isaac K Carney5 shared
Ogechi C Nna4 shared
Maya M Davis4 shared
Ifechimere I Okafor3 shared
Russell J Glapion3 shared
Brandy L Couillard3 shared
Full investigator report
Get the verbatim findings behind Edmund F Mrak's 600 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site